We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel Skin Patch Offers Solution to Antibiotic Resistance

By HospiMedica International staff writers
Posted on 18 Jan 2018
A new study describes how a microarray patch that administers drugs directly into the bloodstream could provide an answer to the antibiotic resistance crisis.

Under development at Queen's University Belfast (QUB; United Kingdom), the unique antibiotic patch containing multiple 400 μm hydrogel-forming microneedle arrays that painlessly pierce the skin, turning into a gel-like material that consistently keeps the micropores open at an approximate 200 μm diameter. This provides a new avenue for delivering antibiotics directly into the bloodstream, thus bypassing the antibiotic-resistant gut bacteria and extending the lifespan of currently available antibiotics.

Image: An example of a hydrogel microneedle patch (Photo courtesy of Ryan Donnelly/QUB).
Image: An example of a hydrogel microneedle patch (Photo courtesy of Ryan Donnelly/QUB).

According to the researchers, oral administration of antibiotics contributes significantly to development of antibiotic resistance, since small quantities of the drug often finds its way into the colon, a perfect breeding ground for imminent drug-resistant bacteria. Injection of the antibiotic directly into the blood stream can significantly reduce the development of resistance amongst gut bacteria relative to oral administration, especially if the antibiotic is predominantly excreted through the kidneys. The study was published on December 2, 2017, in Journal of Controlled Release.

“For the first time, we’re in control of the rate at which medicine goes into the skin. We hope to show that this unique antibiotic patch prevents resistance development,” said study co-author professor of pharmaceutical technology Ryan Donnelly, PhD. “If we are successful, this approach will significantly extend the lifespan of existing antibiotics, allowing time for development of the next generation of antibiotics. In doing so, this work has the potential to save many lives.”

Microneedles as a technique for drug delivery enhancement were primarily designed for facilitating percutaneous drug delivery. Since the emergence of solid microneedles two decades ago, which simply pierced the stratum corneum in order to enhance topical drug delivery, the technique has progressed in various modifications such as hollow, coated, dissolving, and hydrogel forming microneedles. In their turn, the modifications have resulted in new mechanisms of drug delivery enhancement, followed by an expansion of applicability range in terms of targeted tissues and organs.

Related Links:
Queen's University Belfast


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Phlebotomy Chair
CHE03/BH
New
Cementless Partial Knee
Oxford

Latest Critical Care News

Non-Invasive Brain Scanner to Enable Real-Time Brain Injury Monitoring and Rapid TBI Detection

Power-Free Color-Changing Strain Sensor Enables Applications in Health Monitoring

AI-Powered Wearable ECG Monitor to Improve Early Detection of Cardiovascular Disease